Publications:

A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research

Jang, H Josh HJ; Hostetter, Galen G; MacFarlane, Alexander W AW; Madaj, Zachary Z; Ross, Eric A EA; Hinoue, Toshinori T; Kulchycki, Justin R JR; Burgos, Ryan S RS; Tafseer, Mahvish M; Alpaugh, R Katherine RK; Schwebel, Candice L CL; Kokate, Rutika R; Geynisman, Daniel M DM; Zibelman, Matthew R MR; Ghatalia, Pooja P; Nichols, Peter W PW; Chung, Woonbok W; Madzo, Jozef J; Hahn, Noah M NM; Quinn, David I DI; Issa, Jean-Pierre J JJ; Topper, Michael J MJ; Baylin, Stephen B SB; Shen, Hui H; Campbell, Kerry S KS; Jones, Peter A PA; Plimack, Elizabeth R ER

Publication Date: 2023-03-16

Variant appearance in text: KMT2D: Q827H

PubMed Link: 36928921

Variant Present in the following documents:

• ccr-22-3642_supplementary_tables_1_suppts1.xlsx, sheet 3

View BVdb publication page

A performance evaluation study: Variant annotation tools - the enigma of clinical next generation sequencing (NGS) based genetic testing.

Journal Of Pathology Informatics

Tuteja, Sachleen S; Kadri, Sabah S; Yap, Kai Lee KL

Publication Date: 2022

Variant appearance in text: KMT2D: 2481A>T; Q827H

PubMed Link: 36268089

Variant Present in the following documents:

• Main text
• main.pdf

View BVdb publication page

PPARγ Targets-Derived Diagnostic and Prognostic Index for Papillary Thyroid Cancer.

Cancers

Kim, Jaehyung J; Kim, Soo Young SY; Ma, Shi-Xun SX; Kim, Seok-Mo SM; Shin, Su-Jin SJ; Lee, Yong Sang YS; Chang, Hojin H; Chang, Hang-Seok HS; Park, Cheong Soo CS; Lim, Su Bin SB

Publication Date: 2021-10-12

Variant appearance in text: KMT2D: Gln827His

PubMed Link: 34680260

Variant Present in the following documents:

• Main text
• cancers-13-05110.pdf

View BVdb publication page

Interrogating Mutant Allele Expression via Customized Reference Genomes to Define Influential Cancer Mutations.

Scientific Reports

Grant, Adam D AD; Vail, Paris P; Padi, Megha M; Witkiewicz, Agnieszka K AK; Knudsen, Erik S ES

Publication Date: 2019-09-04

Variant appearance in text: KMT2D: Q827H

PubMed Link: 31484939

Variant Present in the following documents:

• 41598_2019_48967_MOESM2_ESM.xls, sheet 1

View BVdb publication page

Patient-specific molecular alterations are associated with metastatic clear cell renal cell cancer progressing under tyrosine kinase inhibitor therapy.

Oncotarget

Dietz, Steffen S; Sültmann, Holger H; Du, YueJun Y; Reisinger, Eva E; Riediger, Anja Lisa AL; Volckmar, Anna-Lena AL; Stenzinger, Albrecht A; Schlesner, Matthias M; Jäger, Dirk D; Hohenfellner, Markus M; Duensing, Stefan S; Grüllich, Carsten C; Pahernik, Sascha S

Publication Date: 2017-09-26

Variant appearance in text: KMT2D: Q827H

PubMed Link: 29088767

Variant Present in the following documents:

• oncotarget-08-74049-s002.xlsx, sheet 2

View BVdb publication page